These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 37456389)

  • 21. Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
    McEvoy JP; Byerly M; Hamer RM; Dominik R; Swartz MS; Rosenheck RA; Ray N; Lamberti JS; Buckley PF; Wilkins TM; Stroup TS
    JAMA; 2014 May; 311(19):1978-87. PubMed ID: 24846035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature.
    Belteczki Z; Ujvari J; Dome P
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):148-153. PubMed ID: 34132673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response.
    Luchini F; Medda P; Mariani MG; Mauri M; Toni C; Perugi G
    World J Psychiatry; 2015 Jun; 5(2):182-92. PubMed ID: 26110120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
    Chiou YJ; Lee Y; Lin CC; Huang TL
    Medicine (Baltimore); 2015 Oct; 94(43):e1752. PubMed ID: 26512569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting.
    Suchandra HH; Reddi VSK; Aandi Subramaniyam B; Muliyala KP
    Aust N Z J Psychiatry; 2021 Oct; 55(10):993-1004. PubMed ID: 33124447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of atypical antipsychotics in the treatment of catatonia.
    Van Den Eede F; Van Hecke J; Van Dalfsen A; Van den Bossche B; Cosyns P; Sabbe BG
    Eur Psychiatry; 2005 Aug; 20(5-6):422-9. PubMed ID: 15964746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms.
    Northoff G; Koch A; Wenke J; Eckert J; Böker H; Pflug B; Bogerts B
    Mov Disord; 1999 May; 14(3):404-16. PubMed ID: 10348462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of schizophrenia with catatonic symptoms: A narrative review.
    Caroff SN; Ungvari GS; Gazdag G
    Schizophr Res; 2024 Jan; 263():265-274. PubMed ID: 36404216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic-induced catatonia in two hospitalized patients.
    Gugger JJ; Saad M; Smith C
    J Pharm Pract; 2012 Apr; 25(2):250-4. PubMed ID: 22048928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.
    Brogna P; Colasuonno R; Di Michele F; Paterniti AM; Talamo A; Ribolsi M; Jannini TB; Siracusano A; Niolu C
    Riv Psichiatr; 2020; 55(4):236-239. PubMed ID: 32724236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
    Desai S; Hirachan T; Toma A; Gerolemou A
    Cureus; 2021 Jun; 13(6):e15818. PubMed ID: 34306883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    Menard ML; Yagoubi F; Drici M; Lavrut T; Askenazy F
    Encephale; 2013 May; 39 Suppl 1():S29-35. PubMed ID: 23219595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):462-8. PubMed ID: 17188791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catatonia, Pregnancy, and Electroconvulsive Therapy (ECT).
    Gandhi K; Nguyen K; Driscoll M; Islam Z; Maru S
    Case Rep Psychiatry; 2023; 2023():9601642. PubMed ID: 37456983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders.
    Peter-Ross EM
    Med Hypotheses; 2018 Apr; 113():54-64. PubMed ID: 29523295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature.
    Barnett BS; Balaji D; Weleff J; Carroll BT
    J Acad Consult Liaison Psychiatry; 2023; 64(3):277-293. PubMed ID: 36586471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.